Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation

doi:10.5306/wjco.v8.i2.168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8684)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-10) series.

Item

Count

PDF

489

WORD

280

HTML

3960

Tables (1-10)

313

Sum=5042

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1260

Download

2127

Sum=3387

Apr 10, 2017 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Oncol. Apr 10, 2017; 8(2): 168-177
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.168

Table 2 Stomach and duodenum polyps

	Patients		Patients
Fundus	34 (49.3%)	Bulb	7 (13.5%)
Antrum	7 (10.1%)	Ii°/iii° portion	35 (67.3%)
Fundus + antrum	28 (40.6%)	Bulb+ii°/iii°	10 (19.2%)
Total stomach	69 (100%)	Total duodenum	52 (100%)

Citation: Lami G, Galli A, Macrì G, Dabizzi E, Biagini MR, Tarocchi M, Messerini L, Valanzano R, Milani S, Polvani S. Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation. World J Clin Oncol 2017; 8(2): 168-177
URL: https://www.wjgnet.com/2218-4333/full/v8/i2/168.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i2.168